Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has shared its schedule of upcoming meetings with analysts and institutional investors. On March 18, 2026, the company will hold a Non-Deal Roadshow (NDR) with Elara, based in the USA. This will be followed by one-on-one meetings on March 19 and March 20, 2026. The filing was made under SEBI's Listing Regulations (Regulation 30) to keep the exchanges informed. The company has noted that the schedule may change due to last-minute requirements from any party involved.
This is a routine disclosure and does not carry any business or financial information. Short-term stock movement is unlikely, though investor sentiment may be mildly positive given active engagement with institutional investors and a US-based broker.